№ lp_2_3_37810
File format: docx Character count: 28425 File size: 3289 KB
This document presents experimental methods and results regarding HBV-specific T cell responses in relation to HBsAg loss after discontinuation of nucleos(t)ide analogue therapy.
Note: Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Supplementary Table 1. Mean and median survival analysis of cumulative HBsAg, cumulative HBV DNA, and their ratio in immune tolerance duration
Year: -
Region / City: -
Subject: Immune tolerance duration analysis
Document Type: Research data
Organization / Institution: -
Author: -
Target Audience: -
Period of Validity: -
Approval Date: -
Date of Changes: -
Contextual Description: Research data on the survival analysis of cumulative HBsAg, HBV DNA, and their ratio in immune tolerance duration.
Asian Pacific Association for the Study of the Liver Consensus Recommendations on Hepatocellular Carcinoma-2010APASL Consensus Statements and Management Algorithms for Hepatitis C Virus Infection-2012Asian-Pacific Consensus statement on the management of chronic hepatitis B: A 2012 update-2012Acute-on-chronic liver failure: An Update on Consensus Recommendations of the Asian Pacific Association for the Study of the Liver (APASL)-2014ASIAN-PACIFIC CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF HEPATITIS B: A 2015 UPDATE-2015APASL consensus statements and recommendation on treatment of hepatitis C-2016APASL consensus statements and recommendations for hepatitis C prevention, epidemiology and laboratory testing-2016ASIAN-PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL) CONSENSUS GUIDELINES ON INVASIVE AND NON-INVASIVE ASSESSMENT OF HEPATIC FIBROSIS: A 2016 UPDA-2016Asia-Pacific clinical practice guideline on the management of hepatocellular carcinoma: a 2016 update-2017APASL clinical practice recommendation: How to treat HCV-infected patients with renal impairment?-2018APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation-2019ACUTE-ON-CHRONIC LIVER FAILURE: CONSENSUS RECOMMENDATIONS OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL), AN UPDATE-2019The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseases-2020Asia-Pacific Association for the Study of the Liver Clinical Practice Guidance: The diagnosis and management of patients with autoimmune hepatitis-2021Budd-Chiari Syndrome: Consensus Guidelines of the Asian Pacific Association for the Study of the Liver (APASL)-2021APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy-2021APASL Clinical Practice Guidance: The diagnosis and management of patients with primary biliary cholangitis-2021APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients-2021Asian Pacific Association for the Study of Liver (APASL) Guidelines: Hepatitis B Virus in Pregnancy-2021Drug-Induced Liver Injury: Asia Pacific Association of Study of Liver Consensus Guidelines-2021Asian Pacific Association for the Study of the Liver Clinical Practice Guidelines on Liver Transplantation-2023Clinical Practice Guidelines on Haemochromatosis: Asian Pacific Association for the Study of the Liver-2023Asia Pacific Association for Study of Liver Guidelines on Management of Ascites in Liver Disease-2023APASL clinical practice guideline on systemic therapy for hepatocellular carcinoma-2024-2024Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management-2024The Asian Pacific Association for the Study of the Liver clinical practice guideline for the diagnosis and management of metabolic dysfunction-associated fatty liver disease-2024APASL CLINICAL PRACTICE GUIDELINES ON THE MANAGEMENT OF ACUTE KIDNEY INJURY IN ACUTE-ON-CHRONIC LIVER FAILURE-2024Acute-on-chronic liver failure (ACLF) - The ‘Kyoto Consensus’: Steps from Asia-2024
Year: 2010-2024
Region / city: Asia-Pacific
Subject: Hepatology
Document Type: Clinical Practice Guidelines
Organization / Institution: Asian Pacific Association for the Study of the Liver (APASL)
Author: APASL
Target Audience: Healthcare professionals
Period of validity: 2010-2024
Date of approval: 2010
Date of revisions: 2024
Context: Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Supplementary material Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review
Year: 2023
Region / City: Global
Subject: Chronic Hepatitis B, Treatment Outcomes, Nucleoside Analogue Agents
Document Type: Systematic Review
Organization / Institution: Not specified
Author: Gloria Sukali et al.
Target Audience: Healthcare professionals, researchers, medical practitioners
Period of validity: Not specified
Approval Date: Not specified
Date of Changes: Not specified
Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma
Year: 2015
Region / City: Istanbul, Turkey
Theme: Hepatology, Hepatitis B, Hepatocellular carcinoma
Document type: Review article
Organization / Institution: Koç University Hospital
Author: Bulent Baran
Target audience: Medical professionals, researchers in hepatology
Period of action: Ongoing
Approval date: June 18, 2015
Revision date: May 6, 2015
Peer review date: February 2, 2015
Published online: June 18, 2015
Topics: Envelope-specific HBsAg nucleostide